註冊並分享邀請連結,可獲得影片播放與邀請獎勵。

IPO Newsroom
@IPONewsroom_
Your IPO newsroom. S-1 filings, pricing updates, debut coverage, and post-IPO performance.
加入 November 2024
109 正在關注    32K 粉絲
Samsung Biologics' $2 billion rights offering was oversubscribed more than five times, drawing bids for 11.9 million shares against 2.3 million offered. The proceeds help fund its acquisition of PolyPeptide, per Dow Jones.
顯示更多